Pay in 4 interest-free payments of $6.65 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
Based on these encouraging preliminary efficacy and safety signals, JSKN003 entered phase 3 trials in December 2023 (NCT06079983) [71]
Normally, this is the last set of clinical trials before a medication can be licensed
Clinically meaningful weight loss typically appears between 8 and 12 weeks of treatment, often coinciding with reaching higher therapeutic doses (1.0 mg or above)
Get more exercise
changing it frequently resets that adaptation Habit formation requires 6-8 weeks of consistent behavior
US$ 22.23
US$ 24.24
US$ 29.47
US$ 21.87
US$ 21.22
